CEO of IGC Pharma, where our mission is to treat Alzheimer's. Extensive experience leading public companies in technology and pharmaceuticals. The Company has four platforms with investigational drugs addressing various stages of Alzheimer's disease. Our lead drug aimed at reducing agitation in Alzheimer's is currently in Phase 2 trials with positive interim data readout. We are also building a foundation model for Alzheimer's with various modalities including PET, MRI, clinical, social, and other data, with the goal of early detection and prediction of disease trajectory, using advanced AI algorithms. Expertise in business modeling, business strategy, acquisitions, IPOs, SEC, SOX, and NYSE compliance.
-
Founder, CeoIgc PharmaPotomac, Md, Us -
Founder, CeoIgc Pharma, Inc. Mar 2023 - PresentIGC has four investigational platform drugs that address Alzheimer's disease, GLP-1r, and pain. Over the past ten years we have assembled an impressive team with deep backgrounds in Alzheimer's, neurology, and neuropsychiatric symptoms. Our most advanced drug that targets neuroinflammation, neurotransmitter imbalance, and CB1r is currently in Phase 2 trials with positive interim data readout.
-
CeoIndia Globalization Capital, Inc. Mar 2008 - Mar 2023The Company had two lines of business: infrastructure, and plant-based products and therapies. The Company’s infrastructure business, based in India and Hong Kong involved the execution of construction projects. The Company's second line of business, located in the U.S. involved plant extracts for therapeutic value. The Company filed several patents for plant based medications for alleviating pain, eating disorders, seizures, and created several over the counter products for these conditions. IGC modified its focus to plant based pharmaceuticals and OTC products and changed its name to IGC Pharma in March 2023.
-
CeoStartec Global Communications 1991 - 2003UsServed as Founder and CEO of Startec Global Communications, an international telecommunications carrier focused on providing voice over Internet protocol (VOIP) services to emerging economies. Startec was the first pure play international long distance telephone carrier. Under Mr. Mukunda’s tenure the company made an initial public offering (IPO) of its equity securities in 1997 on NASDAQ. The Company grew into the third largest VOIP company into the emerging economies with over $250 million in annual revenue, and expanded service to Canada, United Kingdom, France, and Germany. -
AdvisorIntelsat 1987 - 1990Mclean, Va, UsServed as Strategic Planning Advisor. -
AnalystCaine Gressel Midgley Slater, Inc. 1986 - 1987Wall Street boutique firm where I helped structure mortgage backed securities and municipal bonds.
Ram Mukunda Education Details
-
University Of Maryland -
University Of Connecticut
-
WestledgeHigh School
Frequently Asked Questions about Ram Mukunda
What company does Ram Mukunda work for?
Ram Mukunda works for Igc Pharma
What is Ram Mukunda's role at the current company?
Ram Mukunda's current role is Founder, CEO.
What schools did Ram Mukunda attend?
Ram Mukunda attended University Of Maryland, University Of Connecticut, Westledge.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial